Award for leading Spanish ophthalmologist

Article

Dr Jorge Alio, a valued member of Ophthalmology Times Europe?s Editorial Advisory Board, has been acknowledged by The Cornea Research Foundation of America (CRFA) for his technique using Yag laser treatments to eliminate epithelial ingrowth after Lasik.

Dr Jorge Alió, a valued member of Ophthalmology Times Europe’s Editorial Advisory Board, has been acknowledged by The Cornea Research Foundation of America (CRFA) for his technique using Yag laser treatments to eliminate epithelial ingrowth after Lasik.

The Torchbearer Award, presented to Dr Alió, during the ESCRS meeting in Barcelona recognizes individuals whose lifetime service and commitment to the field of vision care has helped light the way for others. It was developed by CRFA Founder Dr Francis W. Price, Jr., MD to recognize dedicated ophthalmic research physicians throughout the world.

The award was made for Dr Alió's work on the development of a non-invasive method to treat glare and halos post laser surgery. According to the CRFA, Epithelial cells rarely grow into the interface between the Lasik flap and underlying stromal bed after primary procedures. However, after re-treatments, where Lasik flaps are lifted and replaced, epithelial ingrowth can occur in up to 5-10% of cases. Dr Alió's innovative treatment creates a dramatic improvement in this condition. Previously flaps had to be re-lifted to remove the cells. The epithelial ingrowth could recur after its removal, and in some cases the Lasik flaps would require suturing down to prevent the epithelial cells from returning. Now with the use of the YAG laser, there are no more flap lifts or sutures to correct this condition providing better outcomes and more comfortable treatments for patients.

To learn more about the Foundation visit www.cornea.org

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.